The calculated Cox regression model (including the potentially prognostic parameters grade, tumor stage, nodal status and metastasis) confirmed the clinical impact of FGFR3 mutation on recurrence-free survival (Supplementary Data S2). The gene discussed is FGFR3; the disease is neoplasm.